In vitro activity of clarithromycin and its 14-hydroxy-metabolite against 203 strains ofHaemophilus influenzae
- 1 May 1992
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 20 (3) , 164-167
- https://doi.org/10.1007/bf01704612
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycinDiagnostic Microbiology and Infectious Disease, 1992
- Clarithromycin, a unique macrolide: A pharmacokinetic, microbiological, and clinical overviewDiagnostic Microbiology and Infectious Disease, 1992
- Activity of clarithromycin and its principal human metabolite against Haemophilus influenzaeAntimicrobial Agents and Chemotherapy, 1991
- The activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae, determined by in-vitro and serum bactericidal testsJournal of Antimicrobial Chemotherapy, 1991
- Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humansAntimicrobial Agents and Chemotherapy, 1990
- Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia modelAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1987
- A Taxonomic Study of the Genus Haemophilus, with the Proposal of a New SpeciesJournal of General Microbiology, 1976
- A RAPID METHOD FOR THE DIFFERENTIATION OF HAEMOPHILUS STRAINS.Acta Pathologica Microbiologica Scandinavica Section B Microbiology and Immunology, 1974
- Novel Method for Detection of β-Lactamases by Using a Chromogenic Cephalosporin SubstrateAntimicrobial Agents and Chemotherapy, 1972